Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
My-Or Diagnostics Ltd. manages a portfolio in the Biotechnology & Pharmaceuticals technology area with 3 pending office actions. These actions are spread across 3 distinct examiners and 3 distinct art units. This level of distribution indicates that the company is pursuing multiple different technical paths or applications within the biotech sector. The involvement of 3 distinct art units suggests that the company's technology is diverse enough to require review from three separate specialized groups.
DUNN, LINDSAY MICHELLE is identified as the busiest examiner, though she only holds 1 pending office action. Because there are 3 pending office actions in total and 3 distinct examiners, the workload is perfectly distributed with each examiner handling exactly one action. This means the company must manage 3 independent prosecution timelines and examiner interactions simultaneously. Such a spread across 3 distinct examiners requires a robust strategy to maintain consistency across the Biotechnology & Pharmaceuticals portfolio.
The data shows that the company's prosecution efforts are active in 3 distinct art units, reflecting a broad technical footprint. With 3 pending office actions currently under review, the company's immediate patent strategy is more diversified than portfolios with a single active case. Practitioners should be prepared to address the specific requirements of each of the 3 distinct examiners to ensure the successful advancement of the 1 busiest examiner pending workload.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUNN, LINDSAY MICHELLE | 1 | 80.0% | +0.0% |
| BAVA, JANKI MAHESH | 1 | 11.1% | +50.0% |
| GREENE, CAROLYN LEE | 1 | 65.3% | +47.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18275481 | METHODS FOR PREVENTING ORAL SENSITIZATION | DUNN, LINDSAY MICHELLE | 11d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17639399 | SKIN MICROBIOME MONITORING FOR IMPROVING SYSTEMIC HEALTH | GREENE, CAROLYN LEE | 9d overdue |
| 18022667 | APPARATUS AND METHOD FOR DETERMINING HEMOGLOBIN LEVELS | BAVA, JANKI MAHESH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17639399 | SKIN MICROBIOME MONITORING FOR IMPROVING SYSTEMIC HEALTH | GREENE, CAROLYN LEE | 9d overdue |
| 18022667 | APPARATUS AND METHOD FOR DETERMINING HEMOGLOBIN LEVELS | BAVA, JANKI MAHESH | — |
| Art Unit | Apps |
|---|---|
| 1644 | 1 |
| 3791 | 1 |
| 1681 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18275481 | METHODS FOR PREVENTING ORAL SENSITIZATION | DUNN, LINDSAY MICHELLE | 1644 | §103 | Final Rejection | 11d overdue | Pending | Aug 02, 2023 |
| 18022667 | APPARATUS AND METHOD FOR DETERMINING HEMOGLOBIN LEVELS | BAVA, JANKI MAHESH | 3791 | §103§112 | Non-Final OA | — | Pending | Feb 22, 2023 |
| 17639399 | SKIN MICROBIOME MONITORING FOR IMPROVING SYSTEMIC HEALTH | GREENE, CAROLYN LEE | 1681 | §101§112 | Non-Final OA | 9d overdue | Pending | Mar 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial